Dr. Lehman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Dermatopathology, 2010 - 2011
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Dermatology, 2007 - 2010
- Gundersen Lutheran Medical FoundationInternship, Transitional Year, 2006 - 2007
- University of Wisconsin School of Medicine & Public HealthClass of 2006
Certifications & Licensure
- ND State Medical License 2023 - 2026
- FL State Medical License 2018 - 2025
- MN State Medical License 2007 - 2025
- American Board of Dermatology Dermatology
- American Board of Dermatology Dermatopathology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Methods Validation Assessment for Study of Inflammatory Skin Disease Start of enrollment: 2019 Jan 14
Publications & Presentations
PubMed
- 47 citationsUndifferentiated pleomorphic sarcoma: Factors predictive of adverse outcomesDaniel S. Winchester, Julia S. Lehman, Tiffany L. Tello, Nicolette T. Chimato, Thomas L. Hocker
Journal of the American Academy of Dermatology. 2018-11-01 - 7 citationsA case of extensive acquired progressive lymphangioma.Sydney C. Larkin, Ashley B. Wentworth, Julia S. Lehman, Megha M. Tollefson
Pediatric Dermatology. 2018-07-01 - 20 citationsEvidence-based guidelines for laboratory screening for infectious diseases before initiation of systemic immunosuppressive agents in patients with autoimmune bullous d...P.J. Keith, David A. Wetter, John W. Wilson, Julia S. Lehman
The British Journal of Dermatology. 2014-12-01
Journal Articles
- Risk Factors for Keratinocyte Carcinoma in Recipients of Allogeneic Hematopoietic Cell TransplantsJeffrey F Scott, Konstantin V Grigoryan, Jeremy S Bordeaux, Meg R Gerstenblith, Julia S Lehman, JAMA Dermatology
Authored Content
- Risk Factors for Keratinocyte Carcinoma in Recipients of Allogeneic Hematopoietic Cell TransplantsApril 2020
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: